Biosynex SA reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 196.6 million compared to EUR 382.5 million a year ago. Net income was EUR 15.6 million compared to EUR 104 million a year ago.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
4.065 EUR | 0.00% | +0.99% | -51.32% |
May. 13 | Biosynex: Oren Bitton appointed Chief Operating Officer | CF |
Apr. 30 | Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-51.32% | 47.5M | |
-6.86% | 12.1B | |
-3.93% | 8.16B | |
+5.62% | 5.78B | |
+30.16% | 5.59B | |
-7.47% | 4.23B | |
-57.20% | 2.87B | |
+12.56% | 2.71B | |
-5.50% | 2.35B | |
+27.38% | 2.21B |
- Stock Market
- Equities
- ALBIO Stock
- News Biosynex
- Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2022